202114-62-3
Chemical Structure
L-Glutamic acid-13C5 hydrate salt
- CAS No.: 202114-62-3
- Formula:13C5H10NNaO5
- Molecular Weight:192.09
IUPAC Name: 2-aminoethan-1-ol-1-13C hydrochloride
InChIKey: GJBHGUUFMNITCI-SUAQCYARSA-M
SMILES: O=[13C](O[Na])[13CH2][13CH2][13C@H](N)[13C](O)=O.O
Biological Activity: L-Glutamic acid-13C5 hydrate salt is the 13C labeled L-Glutamic acid hydrate salt. L-Glutamic acid monosodium hydrate is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA). L-Glutamic acid monosodium hydrate has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid monosodium hydrate can be used in the study of neurological diseases. L-Glutamic acid monosodium hydrate acts at ionotropic and?metabotropic glutamate receptors.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Glutamic acid-13C5 hydrate salt | L-Glutamic acid-13C5 hydrate salt is the 13C labeled L-Glutamic acid hydrate salt. L-Glutamic acid monosodium hydrate is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA). L-Glutamic acid monosodium hydrate has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid monosodium hydrate can be used in the study of neurological diseases. L-Glutamic acid monosodium hydrate acts at ionotropic and?metabotropic glutamate receptors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
